StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.78−0.07 (-3.78%)

Close on Nov 17, 2026Market cap $54.27MP/E –Yield –

XBiotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

XBiotech's price to sales ratio was 465.7× on Jan 31, 2024, against 16.1× a year earlier. Over the last 4 years it ranged from 9.7× to 465.7×, with a median of 17.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024465.7×+59.9
2023Dec 29, 2023405.8×+392.8
2022Dec 30, 202213.0×−4.6
2021Dec 31, 202117.7×+5.8
2020Dec 31, 202011.8×–

More XBiotech figures

See a number that looks wrong?